-+ 0.00%
-+ 0.00%
-+ 0.00%

Tuoxin Pharmaceutical (301089.SZ)'s application to issue shares to specific targets was reviewed and approved by the Shenzhen Stock Exchange

Zhitongcaijing·11/01/2026 22:49:01
Listen to the news

Zhitong Finance App News, Tuoxin Pharmaceutical (301089.SZ) issued an announcement. On November 1, 2026, the company received the “Notice of Opinion Notice from the Audit Center on Tuoxin Pharmaceutical Group Co., Ltd.'s application to issue shares to specific targets” from the Shenzhen Stock Exchange. The Shenzhen Stock Exchange issuance and listing review agency reviewed the company's application documents to issue shares to specific targets, and believed that the company met the issuance conditions, listing conditions and information disclosure requirements. The Shenzhen Stock Exchange will then report it to the China Securities Regulatory Commission to complete the relevant registration procedures in accordance with regulations.